Form 483

Corium Innovations, Inc. Form 483, 2022-11-18

FDA issued a Form 483 to Corium Innovations, Inc. on 2022-11-18 with 3 public-safe observations.

483· Form 483 issuedHuman Drugs3 observations

Corium Innovations, Inc. · Grand Rapids, United States · Issued November 18, 2022

Overview

  • 3 public-safe observations are available for this inspection.
  • 3 structured CFR citations are represented.
  • 3 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

18 Nov 2022
21 CFR 211.110(a)

Control procedures to monitor and validate performance

Cited by Brent M Dehaan, Joseph A Piechocki, Amanda M Dunneback

18 Nov 2022
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Brent M Dehaan, Joseph A Piechocki, Amanda M Dunneback

18 Nov 2022
21 CFR 211.56(c)

Written procedures lacking for use of pesticides etc.

Cited by Brent M Dehaan, Joseph A Piechocki, Amanda M Dunneback

Inspected site

CICorium Innovations, Inc.Grand Rapids, United States

Inspection team

BMBrent M Dehaan
AMAmanda M Dunneback

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.110(a)Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.56(c)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 3 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere